Hostname: page-component-6bf8c574d5-9nwgx Total loading time: 0 Render date: 2025-02-20T12:24:19.372Z Has data issue: false hasContentIssue false
  • English
  • Français

Vibrio vulnificus septicaemia in Japan: an estimated number of infections and physicians' knowledge of the syndrome

Published online by Cambridge University Press:  08 November 2004

K. OSAKA ,
M. KOMATSUZAKI ,
H. TAKAHASHI ,
S. SAKANO  and
N. OKABE
K. OSAKA
Affiliation:
Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
M. KOMATSUZAKI
Affiliation:
Field Epidemiology Training Program, National Institute of Infectious Diseases, Tokyo 162-8640, Japan Department of Infection Control, Jikei University School of Medicine, Tokyo 105-8471, Japan
H. TAKAHASHI
Affiliation:
Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
S. SAKANO
Affiliation:
Department of Public Health, School of Medicine, Hirosaki University, Hirosaki 036-8562, Japan
N. OKABE
Affiliation:
Infectious Disease Surveillance Centre, National Institute of Infectious Diseases, Tokyo 162-8640, Japan
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Questionnaire surveys were implemented to study the incidence and physicians' knowledge of Vibrio vulnificus infections in Japan. Registered emergency physicians were selected by stratified random sampling for a questionnaire survey. A total of 235 out of 386 physicians (61%) responded to the questionnaire and 12 V. vulnificus septicaemia cases were reported from 10 respondents. The annual estimated number of V. vulnificus septicaemia was calculated as 425 (95% CI 238–752). The study also revealed that only 15·7% (95% CI 11·3–21·0) of responding physicians had a basic knowledge of V. vulnificus infection. Education for both physicians and people in the high-risk group for developing the infection (e.g. immunocompromised, chronic liver disease) will be necessary for the prevention, early diagnosis and appropriate treatment of the disease.

Type
Short Report
Information
Epidemiology & Infection , Volume 132 , Issue 5 , October 2004 , pp. 993 - 996
Copyright
© 2004 Cambridge University Press